Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 479% % -8.7%
Debt-to-equity 3518% % 918%
Return On Equity 1630% %
Return On Assets 45% %
Operating Margin 528% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14,629,463 shares 20%
Common Stock, Shares, Outstanding 12,858,047 shares 5.4%
Entity Public Float $10,400,000 USD -92%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 12,300,568 shares 32%
Weighted Average Number of Shares Outstanding, Diluted 12,314,796 shares 28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $19,156,000 USD -60%
General and Administrative Expense $17,679,000 USD -1.6%
Operating Income (Loss) $16,902,000 USD
Nonoperating Income (Expense) $12,919,000 USD -35%
Income Tax Expense (Benefit) $0 USD -100%
Net Income (Loss) Attributable to Parent $29,821,000 USD
Earnings Per Share, Basic 2.42 USD/shares
Earnings Per Share, Diluted 2.42 USD/shares 79%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $48,297,000 USD -38%
Other Assets, Current $20,000 USD -95%
Assets, Current $55,050,000 USD -33%
Property, Plant and Equipment, Net $979,000 USD -29%
Operating Lease, Right-of-Use Asset $5,100,000 USD -11%
Other Assets, Noncurrent $0 USD -100%
Assets $61,776,000 USD -33%
Accounts Payable, Current $879,000 USD -71%
Employee-related Liabilities, Current $2,486,000 USD -11%
Accrued Liabilities, Current $4,232,000 USD -43%
Liabilities, Current $11,346,000 USD -31%
Operating Lease, Liability, Noncurrent $4,943,000 USD -12%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $19,762,000 USD -77%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $204,993,000 USD 13%
Stockholders' Equity Attributable to Parent $42,014,000 USD 640%
Liabilities and Equity $61,776,000 USD -33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,482,000 USD 14%
Net Cash Provided by (Used in) Financing Activities $99,346,000 USD 662207%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 12,858,047 shares 5.4%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $48,944,000 USD -38%
Deferred Tax Assets, Valuation Allowance $98,471,000 USD -7.9%
Deferred Tax Assets, Gross $101,269,000 USD -6.8%
Operating Lease, Liability $5,636,000 USD -9.8%
Depreciation $391,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $29,821,000 USD
Lessee, Operating Lease, Liability, to be Paid $7,061,000 USD -13%
Property, Plant and Equipment, Gross $2,823,000 USD 0%
Operating Lease, Liability, Current $693,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,124,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,092,000 USD 3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,425,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,158,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $58,663,000 USD 80%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,193,000 USD 3%
Additional Paid in Capital $247,005,000 USD 2.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,798,000 USD 59%
Share-based Payment Arrangement, Expense $5,255,000 USD 20%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%